Literature DB >> 2663168

Adrenocorticoid action in the spinal cord: some unique molecular properties of glucocorticoid receptors.

A F De Nicola1, D F Moses, S González, E Ortí.   

Abstract

1. Glucocorticoid hormones affect several functions of the spinal cord, such as synaptic transmission, biogenic amine content, lipid metabolism, and the activity of some enzymes (ornithine decarboxylase, glycerolphosphate dehydrogenase), indicating that this tissue is a target of adrenal hormones. 2. Corticosterone, the main glucocorticoid of the rat, is detected at all regional levels of the spinal cord, and cold stress increases this steroid, predominantly in the cervical regions. 3. Intracellular glucocorticoid receptors have been found in the spinal cord, with higher concentrations in the cervical and lumbar enlargements. Prima facie, these receptors presented biochemical, stereospecifical, and physicochemical properties similar to those of receptors found in other regions of the nervous system. The prevalent form in the spinal cord is the type II receptor, although type I is also present in small amounts. 4. The type II glucocorticoid receptor of the spinal cord shows an affinity lower (Kd 3.5 nM) than that of the hippocampal type II site (Kd 0.7 nM) when incubated with [3H]dexamethasone. This condition may impair the nuclear translocation of the spinal cord receptor. 5. Another peculiar property of spinal cord type II site is a greater affinity for DNA-cellulose binding than the hippocampal receptor during heat-induced transformation. Also, the spinal cord receptor shows resistance to the action of RNAse A, an enzyme which increases DNA-cellulose binding of the hippocampal receptor, indicating that both receptors may be structurally different. 6. Therefore, it is possible that a different subclass of type II, or "classical glucocorticoid receptor," is present in the spinal cord. This possibility makes the cord a useful system for studying diversity of glucocorticoid receptors of the nervous system, especially the relationship between receptor structure and function.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2663168     DOI: 10.1007/bf00713027

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  55 in total

1.  Isolated removal of hypothalamic or other brain nuclei of the rat.

Authors:  M Palkovits
Journal:  Brain Res       Date:  1973-09-14       Impact factor: 3.252

Review 2.  Adrenal steroid receptors and actions in the nervous system.

Authors:  B S McEwen; E R De Kloet; W Rostene
Journal:  Physiol Rev       Date:  1986-10       Impact factor: 37.312

3.  Physicochemical analysis of reversible molybdate effects on different molecular forms of glucocorticoid receptor.

Authors:  T W Hutchens; F S Markland; E F Hawkins
Journal:  Biochem Biophys Res Commun       Date:  1981-11-16       Impact factor: 3.575

4.  Acute effects of intravenous glucocorticoid pretreatment on the in vitro peroxidation of cat spinal cord tissue.

Authors:  E D Hall; J M Braughler
Journal:  Exp Neurol       Date:  1981-07       Impact factor: 5.330

5.  Dynamic aspects of glucocorticoid receptors in the spinal cord of the rat.

Authors:  E Ortí; S Tornello; A F De Nicola
Journal:  J Neurochem       Date:  1985-12       Impact factor: 5.372

6.  Target neurons for [3H]corticosterone in the rat spinal cord.

Authors:  G E Duncan; W E Stumpf
Journal:  Brain Res       Date:  1984-07-30       Impact factor: 3.252

7.  [3H]corticosterone binding in the caudate-putamen.

Authors:  C H Defiore; B B Turner
Journal:  Brain Res       Date:  1983-11-14       Impact factor: 3.252

8.  Identification of modified forms of human glucocorticoid receptors during the cell cycle.

Authors:  R A Currie; J A Cidlowski
Journal:  Endocrinology       Date:  1982-06       Impact factor: 4.736

9.  Effects of a single intravenous glucocorticoids dose on biogenic amine levels in cat lumbar spinal cord.

Authors:  E D Hall; P A McGinley
Journal:  J Neurochem       Date:  1982-06       Impact factor: 5.372

10.  Identification of mineralocorticoid binding sites in rat brain by competition studies and density gradient centrifugation.

Authors:  H Coirini; E T Marusic; A F De Nicola; T C Rainbow; B S McEwen
Journal:  Neuroendocrinology       Date:  1983-11       Impact factor: 4.914

View more
  7 in total

1.  The 21-aminosteroid U-74389F increases the number of glial fibrillary acidic protein-expressing astrocytes in the spinal cord of control and Wobbler mice.

Authors:  M C Gonzalez Deniselle; S L Gonzalez; G G Piroli; A E Lima; A F De Nicola
Journal:  Cell Mol Neurobiol       Date:  1996-02       Impact factor: 5.046

2.  The effect of repeated restraint stress in pain-related behavior induced by nucleus pulposus applied on the nerve root in rats.

Authors:  Kazuhide Uesugi; Miho Sekiguchi; Shin-ichi Kikuchi; Shin-ichi Konno
Journal:  Eur Spine J       Date:  2011-06-23       Impact factor: 3.134

3.  Distribution of adrenocorticoid receptors in the rat CNS measured by competitive PCR and cytosolic binding.

Authors:  L N Marlier; F R Patacchioli; O Porzio; R Chiusaroli; P Borboni; R Lauro; L Angelucci
Journal:  J Mol Neurosci       Date:  1997-08       Impact factor: 3.444

Review 4.  The potential contribution of stress systems to the transition to chronic whiplash-associated disorders.

Authors:  Samuel A McLean
Journal:  Spine (Phila Pa 1976)       Date:  2011-12-01       Impact factor: 3.468

5.  Corticosterone treatment differentially affects adrenocorticoid receptors expression and binding in the hippocampus and spinal cord of the rat.

Authors:  F R Patacchioli; L Angelucci; P Casolini; A Bottone; P Borboni; R Lauro; L N Marlier
Journal:  J Mol Neurosci       Date:  1998-08       Impact factor: 3.444

6.  Immunocytochemical localization of glucocorticoid receptors in the spinal cord: effects of adrenalectomy, glucocorticoid treatment, and spinal cord transection.

Authors:  M Ferrini; S González; T Antakly; A F De Nicola
Journal:  Cell Mol Neurobiol       Date:  1993-08       Impact factor: 5.046

7.  The Effect of Intrathecal Injection of Dextromethorphan on the Experimental Neuropathic Pain Model.

Authors:  Achmad Fahmi; Yunus Kuntawi Aji; Dirga Rachmad Aprianto; Akbar Wido; Asadullah Asadullah; Nurkholis Roufi; Danti Nur Indiastuti; Heri Subianto; Agus Turchan
Journal:  Anesth Pain Med       Date:  2021-06-29
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.